公司資料
Sophia Genetics 股價、新聞與催化劑
- 股票代碼:
- SOPH
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Switzerland
股票表現
8.65 USD (+3.84%)
收盤價
最後更新: 2026年8月21日
355M USD
市值
股價為何變動
As of Aug 21, 2026, SOPH closed up 3.84% at $8.65. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Sophia Genetics is a healthcare technology company focused on data-driven diagnostics and clinical decision support. Its business is centered on applying software to genomic and pathology workflows.
所在地與產業分類
Headquartered in Switzerland and listed on NASDAQ as an ADR, Sophia Genetics sits in healthcare data and diagnostics.
商業模式特徵
The company depends on software adoption, diagnostics workflows, and the value of its data platform across hospitals and labs.
生技產業定位
Sophia Genetics is outside biotech proper and belongs to the diagnostics software layer.
未來催化劑
- SOPHiA Genetics’s catalysts are DDM platform adoption, companion-diagnostic partnerships, and recurring software revenue. The business improves when the analytics workflow becomes more embedded in clinical and biopharma use cases.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。